Dr Steve Bloor is the founder of Videregen, an innovative tissue engineering company. He has over 30 years’ experience working in the medical sector.
Videregen aims to build organ replacements using tissues and patient stem cells. Their innovative technology has potential applications across many disease areas.
Videregen joined Nexus in 2021 after recognising the many benefits the community could provide.
Nexus is home to many companies operating in the healthcare and life sciences sectors. The Leeds city region is widely recognised for its expertise in these areas. Joining this vibrant community was a key driver behind Videregen’s move.
The Nexus team have helped Videregen find collaborators and partners at the University of Leeds. They have also connected them with colleagues at the local and regional hospital trusts.
Access to a lab in Nexus has helped Videregen to secure funding that was not accessible to them before.
With support from the Nexus team, they secured £500,000 from Innovate UK. This has played a key part in facilitating the company’s growth.
Being based at Nexus has allowed Videregen to brings its team together in one location. This enables greater collaboration, sense of community and operational oversight.
Being part of the Nexus community has helped Videregen realise a number of benefits to their business. If you think your company would benefit from the support on offer through Nexus membership, get in touch today.
Investment Zone boosts Leeds’ innovation ambitions and vision
The investment in digital and healthtech will accelerate plans for the Leeds Innovation Arc, kickstarting the development of the Innovation Village on the Leeds General Infirmary site with the refurbishment of the Old Medical School to create a healthtech innovation hub.